3D-Culture System for Heart Regeneration and Cardiac Medicine

3D cultures have gained attention in the field of regenerative medicine for their usefulness as in vitro model of solid tissues. Bottom-up technology to generate artificial tissues or organs is prospective and an attractive approach that will expand as the field of regenerative medicine becomes more translational. We have characterized c-kit positive cardiac stem cells after long-term cultures and established a 3D-nanoculture system using collagen scaffolds. By combining informatics-based studies, including proteomic analyses and microarrays, we sought to generate methods that modeled cardiac regeneration which can ultimately be used to build artificial hearts. Here, we describe the use of biodegradable beads or 3D cultures to study cardiac regeneration. We summarize recent work that demonstrates that, by using a combination of molecular analyses with 3D cultures, it is possible to evaluate concise mechanisms of solid tissue stem cell biology.

[1]  D. Torella,et al.  Adult Cardiac Stem Cells Are Multipotent and Support Myocardial Regeneration , 2003, Cell.

[2]  N. Kawaguchi Stem cells for cardiac regeneration and possible roles of the transforming growth factor-β superfamily , 2012, Biomolecular concepts.

[3]  Y. Furutani,et al.  Prospective In Vitro Models of Channelopathies and Cardiomyopathies , 2012, Stem cells international.

[4]  Nikolay Bazhanov,et al.  Aggregation of human mesenchymal stromal cells (MSCs) into 3D spheroids enhances their antiinflammatory properties , 2010, Proceedings of the National Academy of Sciences.

[5]  Jeffrey H. Omens,et al.  Increased Infarct Wall Thickness by a Bio-Inert Material Is Insufficient to Prevent Negative Left Ventricular Remodeling after Myocardial Infarction , 2011, PloS one.

[6]  E. Braunwald Congestive heart failure: a half century perspective , 2001 .

[7]  T. Nakanishi,et al.  Cell Shape and Cardiosphere Differentiation: A Revelation by Proteomic Profiling , 2013, Biochemistry research international.

[8]  Danielle Rockwood,et al.  Three-dimensional culture alters primary cardiac cell phenotype. , 2010, Tissue engineering. Part A.

[9]  Shunichi Homma,et al.  Composite scaffold provides a cell delivery platform for cardiovascular repair , 2011, Proceedings of the National Academy of Sciences.

[10]  N. Kawaguchi Adult cardiac-derived stem cells: differentiation and survival regulators. , 2011, Vitamins and hormones.

[11]  Tong Hao,et al.  Functional improvement of infarcted heart by co-injection of embryonic stem cells with temperature-responsive chitosan hydrogel. , 2009, Tissue engineering. Part A.

[12]  Jürgen Hescheler,et al.  Global transcriptional profiles of beating clusters derived from human induced pluripotent stem cells and embryonic stem cells are highly similar , 2010, BMC Developmental Biology.

[13]  Jennifer M. Singelyn,et al.  Injectable Materials for the Treatment of Myocardial Infarction and Heart Failure: The Promise of Decellularized Matrices , 2010, Journal of cardiovascular translational research.

[14]  P. Stayton,et al.  Delivery of basic fibroblast growth factor with a pH-responsive, injectable hydrogel to improve angiogenesis in infarcted myocardium. , 2011, Biomaterials.

[15]  Jennifer M. Singelyn,et al.  Naturally derived myocardial matrix as an injectable scaffold for cardiac tissue engineering. , 2009, Biomaterials.

[16]  E. Braunwald,et al.  Congestive Heart Failure: Fifty Years of Progress , 2000, Circulation.

[17]  T. Ichisaka,et al.  Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors , 2007, Cell.

[18]  Sean P. Palecek,et al.  Functional Cardiomyocytes Derived From Human Induced Pluripotent Stem Cells , 2009, Circulation research.

[19]  Masayuki Yamato,et al.  Concise Review: Cell Therapy and Tissue Engineering for Cardiovascular Disease , 2012, Stem cells translational medicine.

[20]  T. Okano,et al.  Cell sheet engineering for myocardial tissue reconstruction. , 2003, Biomaterials.

[21]  Peter W Zandstra,et al.  Creation of mouse embryonic stem cell-derived cardiac cell sheets. , 2011, Biomaterials.

[22]  S. Yamanaka,et al.  Cell line-dependent differentiation of induced pluripotent stem cells into cardiomyocytes in mice. , 2010, Cardiovascular research.

[23]  T. Okano,et al.  A novel recovery system for cultured cells using plasma-treated polystyrene dishes grafted with poly(N-isopropylacrylamide). , 1993, Journal of biomedical materials research.

[24]  A Ratcliffe,et al.  Scaffold-Based Three-Dimensional Human Fibroblast Culture Provides a Structural Matrix That Supports Angiogenesis in Infarcted Heart Tissue , 2001, Circulation.

[25]  P. Bourgine,et al.  Tissue decellularization by activation of programmed cell death. , 2013, Biomaterials.

[26]  D. Mozaffarian,et al.  Heart disease and stroke statistics--2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. , 2009, Circulation.

[27]  Gordon Keller,et al.  SIRPA is a specific cell-surface marker for isolating cardiomyocytes derived from human pluripotent stem cells , 2011, Nature Biotechnology.

[28]  Rumiko Matsuoka,et al.  Micro and nano-scale in vitro 3D culture system for cardiac stem cells. , 2010, Journal of biomedical materials research. Part A.

[29]  A. DeMaria,et al.  Catheter-deliverable hydrogel derived from decellularized ventricular extracellular matrix increases endogenous cardiomyocytes and preserves cardiac function post-myocardial infarction. , 2012, Journal of the American College of Cardiology.

[30]  T. Okano,et al.  Thermo‐responsive polymeric surfaces; control of attachment and detachment of cultured cells , 1990 .

[31]  D. Mozaffarian,et al.  Heart disease and stroke statistics--2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. , 2009, Circulation.

[32]  R. Matsuoka,et al.  Characterization of long-term cultured c-kit+ cardiac stem cells derived from adult rat hearts. , 2010, Stem cells and development.

[33]  E. Sasaki,et al.  Nongenetic method for purifying stem cell–derived cardiomyocytes , 2010, Nature Methods.

[34]  S. Yamanaka,et al.  Induction of Pluripotent Stem Cells from Mouse Embryonic and Adult Fibroblast Cultures by Defined Factors , 2006, Cell.

[35]  D. Malan,et al.  Cardiomyocytes Obtained From Induced Pluripotent Stem Cells With Long-QT Syndrome 3 Recapitulate Typical Disease-Specific Features In Vitro , 2011, Circulation research.

[36]  Doris A Taylor,et al.  Perfusion-decellularized matrix: using nature's platform to engineer a bioartificial heart , 2008, Nature Medicine.

[37]  R. Matsuoka,et al.  Myogenic differentiation in atrium‐derived adult cardiac pluripotent cells and the transcriptional regulation of GATA4 and myogenin on ANP promoter , 2010, Genes to cells : devoted to molecular & cellular mechanisms.

[38]  Marius Wernig,et al.  Comparison of contractile behavior of native murine ventricular tissue and cardiomyocytes derived from embryonic or induced pluripotent stem cells , 2010, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[39]  M. Pfeffer,et al.  Ventricular enlargement and remodeling following acute myocardial infarction: mechanisms and management. , 1991, The American journal of cardiology.

[40]  Milica Radisic,et al.  Functional assembly of engineered myocardium by electrical stimulation of cardiac myocytes cultured on scaffolds , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[41]  A. Khademhosseini,et al.  Microscale technologies for tissue engineering and biology. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[42]  R. Matsuoka,et al.  TGF-beta superfamily regulates a switch that mediates differentiation either into adipocytes or myocytes in left atrium derived pluripotent cells (LA-PCS). , 2010, Biochemical and biophysical research communications.

[43]  Ngan F Huang,et al.  Injectable biopolymers enhance angiogenesis after myocardial infarction. , 2005, Tissue engineering.

[44]  Richard T. Lee,et al.  Injectable Self-Assembling Peptide Nanofibers Create Intramyocardial Microenvironments for Endothelial Cells , 2005, Circulation.

[45]  Lior Gepstein,et al.  Modelling the long QT syndrome with induced pluripotent stem cells , 2011, Nature.

[46]  S. Yuasa,et al.  Induced Pluripotent Stem Cells in Cardiovascular Medicine , 2011, Stem cells international.

[47]  R. Matsuoka,et al.  Proteomic comparison of spherical aggregates and adherent cells of cardiac stem cells. , 2011, International journal of cardiology.

[48]  R. Matsuoka,et al.  c-kitpos GATA-4 High Rat Cardiac Stem Cells Foster Adult Cardiomyocyte Survival through IGF-1 Paracrine Signalling , 2010, PloS one.

[49]  Masayuki Yamato,et al.  Regenerative Therapies Using Cell Sheet-Based Tissue Engineering for Cardiac Disease , 2011, Cardiology research and practice.

[50]  S. Shroff,et al.  Engineered early embryonic cardiac tissue retains proliferative and contractile properties of developing embryonic myocardium. , 2006, American journal of physiology. Heart and circulatory physiology.

[51]  J. Yamashita ES and iPS cell research for cardiovascular regeneration. , 2010, Experimental cell research.

[52]  Harald C Ott,et al.  Organ engineering based on decellularized matrix scaffolds. , 2011, Trends in molecular medicine.